Professor Matt Higgins conferred EMBO membership
EMBO membership recognises outstanding achievements
Congratulations to Professor Matt Higgins, FMedSci, who has been selected as one of 69 new members to join the EMBO community of leading life scientists in 2025. EMBO Membership is conferred in recognition of outstanding achievements and is a lifelong honour. New members become part of a community of more than 2,100 life scientists across Europe and around the world.
EMBO and its members help shape the future direction of life sciences by actively participating in EMBO initiatives. Each year, new members are selected through nomination and election by the existing EMBO Membership to ensure the representation of diverse research fields responding to emerging trends.
Professor Higgins, EP Abraham Chair of Structural Biology between Oxford’s Department of Biochemistry, the Kavli Institute for NanoScience Discovery, and the Dunn School of Pathology, says: “It is an honour to accept membership of EMBO on behalf of my wonderful research team. It is so important that scientific research is unconstrained by national borders and EMBO plays a powerful role in promoting life sciences across Europe. It will be a pleasure to engage with colleagues across the continent as an EMBO member to help further this aim.”
Ana Domingos, Professor of Neuroscience at the Department of Physiology, Anatomy and Genetics at the University of Oxford, has also been selected this year. All new members for 2025 will be formally welcomed at the next EMBO Members’ Meeting in Heidelberg, Germany in October. A directory listing every member with affiliation and subject area is available online.
EMBO Director Fiona Watt says: “A major strength of EMBO lies in the excellence and dedication of its members. Science thrives on global collaboration, and the annual election of the new EMBO Members and Associate Members brings fresh energy and inspiration to our community. We are honoured to welcome this remarkable group of scientists to the EMBO Membership. Their ideas and contributions will enrich the organization and help advance the life sciences internationally.”
See the full EMBO news story here.
.
